Cover Image

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects

Background: This study aimed to investigate the pharmacokinetics, safety, and immunogenicity of recombinant humanized anti-human IL-6R monoclonal antibody injection, LZM008, and evaluate the pharmacokinetic similarity between LZM008 and tocilizumab (ACTEMRA®) in Chinese healthy male subjects.Researc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Guoying Cao (Author), Jingjing Wang (Author), Jinjie He (Author), Yingying Hu (Author), Haijing Yang (Author), Linling Que (Author), Xianghong Gu (Author), Jicheng Yu (Author), Xiaojie Wu (Author), Jufang Wu (Author), Wei Fang (Author), Qing He (Author), Jing Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tocilizumab (Actemra)
by: Martin Sheppard, et al.
Published: (2017)

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men
by: Hong Zhang, et al.
Published: (2021)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
by: Haijing Yang, et al.
Published: (2022)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
by: Xingchen Bian, et al.
Published: (2024)

Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system
by: An Q, et al.
Published: (2019)

A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers
by: Jin Wang, et al.
Published: (2019)

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
by: Shanshan Li, et al.
Published: (2023)

A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects
by: Hongjie Qian, et al.
Published: (2023)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
by: Yingying Hu, et al.
Published: (2023)

Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes
by: Xiaojie Wu, et al.
Published: (2024)

Pharmacoeconomic analysis of Actemra<sup>®</sup> in first-line treatment of rheumatoid arthritis in the modes of combination and monotherapy
by: S. K. Zyryanov, et al.
Published: (2018)

Pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects
by: Hendrik Wessels, et al.
Published: (2019)

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
by: Kai Huang, et al.
Published: (2021)

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects
by: Karsten Roth, et al.
Published: (2019)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
by: Yuancheng Chen, et al.
Published: (2023)

Analysis of 1 008 cases of superficial fungal infections of the skin and their pathogens
by: Zongling WANG, et al.
Published: (2024)

Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects
by: Hanjing Chen, et al.
Published: (2022)

Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis
by: Rui Hu, et al.
Published: (2023)

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations
by: Yu Wang, et al.
Published: (2022)

Clinicial Report: Initial Alignment with •008" Pulse Straightened Supreme Wilcock Wire in Lingual Orthodontics
by: Lew Kenneth KK
Published: (1991)

Cohort Prospective Study to Evaluate Immunogenicity of Epodion® (Biosimilar Epoetin-α) in Anemia Associated with Chronic Kidney Disease (CKD) Patients
by: Nova Angginy, et al.
Published: (2022)

Biosimilars
Published: (2022)

Biosimilars
by: Emel Bülbül Başkan
Published: (2022)

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects
by: Hong Zhang, et al.
Published: (2021)

Patient Satisfaction of General Dermatology Providers: A Quantitative and Qualitative Analysis of 38,008 Online Reviews
by: Dawn Queen, et al.
Published: (2021)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
by: Rania M. Sarhan, et al.
Published: (2022)

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
by: Alina Uifălean, et al.
Published: (2018)

Biosimilars in Europe
Published: (2023)

IMPLEMENTASI METODE DISKUSI DENGAN PENGGUNAAN WHATSAPP DALAM PEMBELAJARAN IPS DI SDN 008 SIMPANG GAUNG
by: Siti Jariyah
Published: (2022)

HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic properties
by: Jibin Zhang, et al.
Published: (2020)

A Pilot Study on Tocilizumab in Very-Late-Onset Myasthenia Gravis
by: Yang TT, et al.
Published: (2023)

Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, double‐blind, parallel‐controlled, phase 1 study
by: Hong Zhang, et al.
Published: (2021)

Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial
by: Chris Wynne, et al.
Published: (2020)

Patient Satisfaction of General Dermatologists: A Quantitative and Qualitative Analysis of 38,008 Online Reviews by Gender and Years of Experience
by: Megan H. Trager, et al.
Published: (2022)

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study
by: Fang Wang, et al.
Published: (2023)

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
by: Qiu Wei, et al.
Published: (2021)

Prevalence, clinical characteristics, and 3-dimensional radiographic analysis of supernumerary teeth in Guangzhou, China: a retrospective study
by: Lidan He, et al.
Published: (2023)

The impact of caries status on supragingival plaque and salivary microbiome in children with mixed dentition: a cross-sectional survey
by: Xiaoxia Yang, et al.
Published: (2021)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
by: Yaxin Fan, et al.
Published: (2022)

Biosimilars in pemphigus vulgaris
by: Sharmila Patil, et al.
Published: (2014)